Pharmacokinetics and Tolerability of Vortioxetine (Lu AA21004) in Child and Adolescent Patients With Depressive or Anxiety Disorder

NCT01491035 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

INDUSTRY

Sponsor class

Conditions

Depressive Disorder
Anxiety Disorder

Interventions

DRUG: Vortioxetine
DRUG: Vortioxetine
DRUG: Vortioxetine
DRUG: Vortioxetine

Sponsor

H. Lundbeck A/S